Study protocol of a phase 2, randomised, placebo-controlled, double-blind, adaptive, parallel group clinical study to evaluate the efficacy and safety of recombinant alpha-1-microglobulin in subjects at high risk for acute kidney injury following open-chest cardiac surgery (AKITA trial)

User: Guest

Document type:: Zeitschriftenaufsatz
Author(s):: Mazer, C David ; Siadati-Fini, Niloufar ; Boehm, Johannes ; Wirth, Felix ; Myjavec, Andrej ; Brown, Craig D ; Koyner, Jay L ; Boening, Andreas ; Engelman, Daniel T ; Larsson, Tobias E ; Renfurm, Ronny ; de Varennes, Benoit ; Noiseux, Nicolas ; Thielmann, Matthias ; Lamy, Andre ; Laflamme, Maxime ; von Groote, Thilo ; Ronco, Claudio ; Zarbock, Alexander
Title:: Study protocol of a phase 2, randomised, placebo-controlled, double-blind, adaptive, parallel group clinical study to evaluate the efficacy and safety of recombinant alpha-1-microglobulin in subjects at high risk for acute kidney injury following open-chest cardiac surgery (AKITA trial)
Keywords:: Anaesthesia ; Cardiac surgery ; Acute renal failure ; Adult intensive & critical care
Journal title:: BMJ Open
Year:: 2023
Journal volume:: 13
Journal issue:: 4
Fulltext / DOI:: doi:10.1136/bmjopen-2022-068363
Publisher:: British Medical Journal Publishing Group
E-ISSN:: 2044-6055
Date of publication:: 06.04.2023
BibTeX

Occurrences: